Over the last five years, Cambridge Healthtech Institute’s Biomarker Series has become the premier producer of cutting-edge meetings focusing on biomarker discovery and implementation. This year, the Biomarker Series returns to Europe for its Second Annual event.
Biomarkers Europe 2007 offers a comprehensive program, covering all aspects of biomarker translation and implementation in the clinic. Drawing on the expertise of producing a diverse array of biomarker meetings, Biomarkers Europe will feature the best examples and case studies in all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline, including safety and efficacy assessment in drug discovery/development, biomarker translation from pre-clinical to clinical studies, biomarker validation and utility in clinical trials, and biomarker assay development and validation.
Sessions Include:
- Biomarkers in Translational Medicine
- Pharmacogenomics/Pharmacodiagnostics
- Biomarker Assay Development and Validation
- Clinical Validation of Biomarkers
- Biomarkers in Clinical Pharmacology
- Biomarkers for Patient Selection
- Biomarkers to Monitor Response to Therapy
- Toxicity Biomarkers
- Biomarkers for Molecular Diagnostics
To ensure the quality of the program, all proposals will be reviewed by the
Scientific Advisory Committee.
Deadline for submission is Friday, April 20, 2007.
To submit a proposal for consideration please
click here.
For more information, please contact:
Julia Boguslavsky, Conference Director, Cambridge Healthtech Institute
E-mail: juliab@healthtech.com
For sponsorship information, please contact:
Cambridge
Healthtech Institute’s Biomarker Series Presents the 
